36
Participants
Start Date
May 22, 2018
Primary Completion Date
December 10, 2019
Study Completion Date
May 13, 2020
Efavaleukin alfa
Efavaleukin alfa administered as a subcutaneous injection.
Placebo
Placebo administered as a subcutaneous injection.
Research Site, Sofia
Research Site, Berlin
Research Site, A Coruña
Research Site, Duncansville
Research Site, Anniston
Research Site, Lansing
Research Site, Frankfurt am Main
Research Site, Dallas
Research Site, Torrance
Research Site, Józefów
Research Site, Krakow
Research Site, Poznan
Research Site, Stalowa Wola
Research Site, Świdnik
Research Site, Wroclaw
Lead Sponsor
Amgen
INDUSTRY